Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TLPLDC Consortium
Austin, Texas, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
The TLPLDC vaccine has shown improved disease-free survival in per-protocol analysis of Phase IIb trials for patients with resected Stage III/IV melanoma, with a strong safety profile and encouraging trends toward long-term benefit compared to placebo[4][5][7].
- Therapeutic areas
- Oncology
- Modalities
- Dendritic cell therapyVaccineBiologic
- Industry
- Biotech
02
Partnerships
Academic collaborations with major U.S. cancer centers (Cedars-Sinai, San Antonio Military Medical Center, The Angeles Clinic)Collaborative clinical trials with investigators at multiple academic sites
Beyond the preview
Go deeper on TLPLDC Consortium.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TLPLDC Consortium.